Tecovirimat for the Treatment of Mpox.

N Engl J Med · 2026 · PMC13440037 · PMID 41740032

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While there was a trend toward faster HMPXV DNA clearance in index lesions at Day 8 in tecovirimat compared with placebo recipients, it did not reach statistical significance, and there was no difference at 15 days.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.